What have we learnt from “real world” data, observational studies and meta-analyses-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

What have we learnt from “real world” data, observational studies and meta-analyses

Published:2018-01-24 Issue: Volume:20 Page:47-58
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Chatterjee Sudesna¹^ORCID,Davies Melanie J¹^ORCID,Khunti Kamlesh¹

Affiliation:

1. Diabetes Research Centre; University of Leicester, Leicester General Hospital; Leicester UK

Funder

National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - East Midlands

NIHR Leicester Biomedical Research Centre

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13178/fullpdf

Reference67 articles.

1. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes;Inzucchi;Diabetes Care,2015

2. Real-world evidence - what is it and what can it tell us?;Sherman;N Engl J Med,2016

3. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy;Tunis;JAMA,2003

4. Randomized controlled trials and real life studies. Approaches and methodologies: a clinical point of view;Saturni;Pulm Pharmacol Ther,2014

5. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6);Buse;Lancet,2009

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Real-World Clinical Data Mining of Post COVID-19 Patients;Advances in Intelligent Networking and Collaborative Systems;2023

2. Determinants of response to the glucagon-like peptide-1 receptor agonists in a type 2 diabetes population in the real-world;Primary Care Diabetes;2022-12

3. Evaluation of Insulin and Glucagon-Like Peptide-1 Analog Sales in Turkey Before the Pandemic Period; Projection for Upcoming Years: A Market Analysis Study;Sakarya Medical Journal;2022-10-07

4. Diabetes Mellitus Type 2, Prediabetes, and Chronic Heart Failure;Cardiovascular Diseases [Working Title];2022-08-27

5. GLP-1 receptor agonists and cardiovascular outcomes in patients with type 2 diabetes: Clinical evidence and best practice;Journal of the American Association of Nurse Practitioners;2022-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3